Last reviewed · How we verify

NCT03673904

High Sensitive CRP in Prediabetics and Diabetes

Completed Last updated 17 September 2018
What this trial tests

trial in Assess Level of High Sensitive CRP in Diabetics and Prediabetics in 180 participants. Completed in 8 March 2018.

Timeline
1 January 2017
Primary endpoint
10 February 2018
8 March 2018

Quick facts

Lead sponsorFayoum University
StatusCompleted
Study typeOBSERVATIONAL
Enrollment180
Start date1 January 2017
Primary completion10 February 2018
Estimated completion8 March 2018

Conditions studied

Sponsor

Fayoum University

Who can join

Adults 18 to 60, any sex, with Assess Level of High Sensitive CRP in Diabetics and Prediabetics. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The aim of this study was to study the level of high-sensitivity CRP in sera of pre-diabetic and newly diagnosed patients with type 2 diabetes mellitus and its correlation with HOMA IR and HbA1c

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other Fayoum University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03673904.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing